Lexicon Pharmaceuticals, Inc. (LXRX)
1.80
-0.02
(-1.10%)
USD |
NASDAQ |
Nov 13, 16:00
1.80
0.00 (0.00%)
After-Hours: 19:59
Lexicon Pharmaceuticals Market Cap : 800.96M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 809.86M |
| November 11, 2026 | 832.11M |
| November 10, 2026 | 827.66M |
| November 09, 2026 | 809.86M |
| November 06, 2026 | 792.06M |
| November 05, 2026 | 716.41M |
| November 04, 2026 | 658.57M |
| November 03, 2026 | 649.67M |
| November 02, 2026 | 640.71M |
| October 30, 2026 | 631.81M |
| October 29, 2026 | 658.51M |
| October 28, 2026 | 660.73M |
| October 27, 2026 | 658.51M |
| October 26, 2026 | 645.16M |
| October 23, 2026 | 631.81M |
| October 22, 2026 | 662.96M |
| October 21, 2026 | 694.10M |
| October 20, 2026 | 703.00M |
| October 19, 2026 | 689.65M |
| October 16, 2026 | 676.30M |
| October 15, 2026 | 734.15M |
| October 14, 2026 | 711.90M |
| October 13, 2026 | 716.35M |
| October 12, 2026 | 734.15M |
| October 09, 2026 | 747.49M |
| Date | Value |
|---|---|
| October 08, 2026 | 783.09M |
| October 07, 2026 | 783.09M |
| October 06, 2026 | 778.64M |
| October 05, 2026 | 774.19M |
| October 02, 2026 | 809.79M |
| October 01, 2026 | 809.79M |
| September 30, 2026 | 834.26M |
| September 29, 2026 | 836.48M |
| September 28, 2026 | 845.38M |
| September 25, 2026 | 798.66M |
| September 24, 2026 | 827.58M |
| September 23, 2026 | 916.57M |
| September 22, 2026 | 969.96M |
| September 21, 2026 | 907.67M |
| September 18, 2026 | 912.12M |
| September 17, 2026 | 905.45M |
| September 16, 2026 | 898.77M |
| September 15, 2026 | 894.32M |
| September 14, 2026 | 880.98M |
| September 11, 2026 | 889.87M |
| September 10, 2026 | 898.77M |
| September 09, 2026 | 956.61M |
| September 08, 2026 | 992.21M |
| September 04, 2026 | 996.66M |
| September 03, 2026 | 1.006B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 129.65B |
| ANI Pharmaceuticals, Inc. | 1.637B |
| Corcept Therapeutics, Inc. | 7.979B |
| Veru, Inc. | 36.15M |
| Johnson & Johnson | 688.44B |
Market Cap Related Metrics
| PS Ratio | 19.22 |
| Price to Book Value | 4.888 |
| Price | 1.80 |
| Earnings Yield | -8.30% |